Search Results

Type of Content
Care & Expertise

News & Events
Sort Results

Showing 31-40 of 664 results for "cancer institute"

Innovation & Technology
TGH Cancer Institute Oncologist to Speak at Prestigious Educational Session at Annual ASCO Meeting
https://www.tgh.org/news/tgh-press-releases/2023/june/tgh-cancer-institute-oncologist-to-speak-at-prestigious-educational-session-at-annual-asco-meeting
Dr. Ivan Borrello, a world-renowned specialist in multiple myeloma, will discuss CAR-T cell therapy and strategies to improve the lives of patients.
Facilities & Expansion
TGH Cancer Institute Expands Its Hematologic Malignancies Program with the Addition of Physician-Scientist Dr. David Swoboda
https://www.tgh.org/news/tgh-press-releases/2021/august/tgh-cancer-institute-expands-its-hematologic-malignancies-program-with-the-addition-of-physician
Accolades & Recognition
Tampa General Hospital Cancer Institute Recognized on Becker’s List of ‘100 Hospital and Health Systems with Great Oncology Programs’ for 2023
https://www.tgh.org/news/tgh-press-releases/2023/october/tgh-cancer-institute-among-100-hospital-and-health-systems-with-great-oncology-programs
Innovation & Technology
Video: TGH Ventures, the TGH Cancer Institute and Synapse Florida Announce the Winner of the TGH Innovation Challenge
https://www.tgh.org/news/tgh-press-releases/2024/march/tgh-ventures-tgh-cancer-institute-synapse-florida-winner-aayu-box-innovation-challenge
The global competition called for new and innovative solutions to provide lifesaving care and reduce cancer mortality in rural areas.
Innovation & Technology
World Renowned Myeloma Expert Ivan Borrello MD to Lead TGH Cancer Institute BMT and Cell Therapies
https://www.tgh.org/news/tgh-press-releases/2022/world-renowned-myeloma-expert-ivan-borrello-md-to-lead-tgh-cancer-institute-bmt-and-cell-therapies
Dr. Borrello is an internationally recognized physician-scientist focusing on developing novel cell-based therapies and transplant platforms for patients with multiple myeloma and other malignancies.
Personnel Announcements, Defining Medicine
Member of the National Academy of Sciences, Dr. Robert C. Gallo, to Lead Microbial Oncology Program at TGH Cancer Institute
https://www.tgh.org/news/tgh-press-releases/2024/july/national-academy-sciences-dr-robert-c-gallo-lead-microbial-oncology-program-tgh-cancer-institute
Dr. Gallo, who discovered the first human RNA virus linked to cancer and co-discovered HIV, effectively saving millions of lives, will focus his work at Tampa General on identifying novel therapeutic targets for difficult-to-treat cancers related to microorganisms.
Article
TGH Cancer Institute Presents
https://www.tgh.org/changingtheparadigminthetreatmentofcancer4-18-2024
Accolades & Recognition, Defining Medicine
Tampa General Hospital Cancer Institute’s Lung Cancer Screening Program is Designated a “Center of Excellence”
https://www.tgh.org/news/tgh-press-releases/2025/may/go2-for-lung-cancer-designates-tampa-general-hospital-center-of-excellence
GO2 for Lung Cancer recognizes the TGH Cancer Institute for its commitment to the highest standards in lung cancer early detection through low dose CT screening.
Article
2024 TGH Cancer Institute Reception at ASH
https://www.tgh.org/tghcancerinstitutereceptionatash
Article
TGH Cancer Institute Presents
https://www.tgh.org/advancements-in-cancer-care

1 2 3 4 5 6 7 67